Fatal outcome of anaphylaxis to camomile-containing enema during labor: A case study

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 6 II, 1998, Pages 1041-1042

  Jensen Jarolim, Erika ^a   Reider, Norbert ^b   Fritsch, Ruth ^a   Breiteneder, Heimo ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fuer Dermatologie und Venerologie Innsbruck   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CHAMOMILE; CORTICOSTEROID; ENEMA; PLANT EXTRACT;

ADULT; ANAPHYLAXIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOTENSION; LARYNX EDEMA; NEWBORN MORTALITY; PRIORITY JOURNAL; PUERPERIUM; RADIOALLERGOSORBENT TEST; SKIN TEST; URTICARIA;

EID: 0032417248     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70345-8     Document Type: Article

References (5)

1. Subiza J, Subiza JL, Hinojosa M, Garcia R, Jerez M, Valdivieso R, et al. Anaphylactic reaction after the ingestion of chamomile tea: a study of cross-reactivity with other Compositae pollens. J Allergy Clin Immunol 1989;84:353-8.
2. Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H, et al. The gene coding for the major birch pollen allergen, Betv I, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935-8.
3. Wen J, Vanek-Krebitz M, Hoffmann-Sommergruber K, Scheiner O, Breiteneder H. The potential of Bel v 1 homologues, a nuclear multigene family as phylogenetic markers in flowering plants. Mol Phylogenet Evol 1997;8:317-33.
4. Ebner C, Hirschwehr R, Bauer L, Breiteneder H, Valenta R, Ebner H, et al. Identification of allergens in fruits and vegetables. IgE-crossreactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95:962-9.
5. Ferreira FD, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.